Algernon Pharmaceuticals (XCNQ:AGN) Other Operating Expense : C$-0.00 Mil (TTM As of Feb. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Other Operating Expense?

Algernon Pharmaceuticals's Other Operating Expense for the three months ended in Feb. 2025 was C$0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2025 was C$-0.00 Mil.

Algernon Pharmaceuticals's quarterly Other Operating Expense declined from Aug. 2024 (C$0.00 Mil) to Nov. 2024 (C$-0.00 Mil) but then increased from Nov. 2024 (C$-0.00 Mil) to Feb. 2025 (C$0.00 Mil).

Algernon Pharmaceuticals's annual Other Operating Expense increased from Aug. 2022 (C$-0.00 Mil) to Aug. 2023 (C$0.00 Mil) but then stayed the same from Aug. 2023 (C$0.00 Mil) to Aug. 2024 (C$0.00 Mil).

Algernon Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Algernon Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Other Operating Expense Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Other Operating Expense

Get a 7-Day Free Trial

Algernon Pharmaceuticals Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Algernon Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00 Mil.

Algernon Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XCNQ:AGN) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

AGNPF:USA AGW0:Germany

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis, and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.

Executives

Christopher Moreau	Director, Senior Officer
Christopher Scott Bryan	Senior Officer
James Kinley	Senior Officer
Harry J.f. Bloomfield	Director
Rajpaul Attariwala	Director
Mark Williams	Director
Howard Gutman	Director
Michael Sadhra	Senior Officer
Kulwant Malhi	10% Security Holder

Algernon Pharmaceuticals Headlines

No Headlines